Thyroid hormone receptor isoforni expression in livers of critically ill patients

Thyroid

Volumn 17, Issue 2, 2007, Pages 105-112

  Thijssen Timmer, Daphne C ^a   Peelers, Robin P ^b   Wouters, Pieter ^c   Weekers, Frank ^c   Visser, Theo J ^b   Fliers, Eric ^a   Wiersinga, Wilmar M ^a   Bakker, Onno ^a   Van Den Berghe, Greet ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; COMPLEMENTARY DNA; DOBUTAMINE; DOPAMINE; ENOXIMONE; GLUCOCORTICOID; INOTROPIC AGENT; INSULIN; ISOPRENALINE; LIOTHYRONINE; MESSENGER RNA; MILRINONE; RNA; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA 1; THYROID HORMONE RECEPTOR ALPHA 2; THYROID HORMONE RECEPTOR BETA 1; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; AUTOPSY; CONTINUOUS INFUSION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; INSULIN TREATMENT; INTENSIVE CARE UNIT; LIVER; LIVER BIOPSY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM;

AGED; CRITICAL ILLNESS; HUMANS; IODIDE PEROXIDASE; LIVER; MALE; MIDDLE AGED; RNA, MESSENGER; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; TRIIODOTHYRONINE;

EID: 33847677741     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0164     Document Type: Article

References (31)

1. Stamm S 2002 Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Human Mol Genet 11:2409-2416.
2. Amir-Ahmady B, Salati LM 2001 Regulation of the processing of glucose-6-phosphate dehydrogenase mRNA by nutritional status. J Biol Chem 276:10514-10523.
3. Ishizuka T, Kajita K, Yamada K, Miura A, Kanoh Y, Ishizawa M, Wada H, Itaya S, Yamamoto M, Yasuda K, Nagata K, Okano Y 1996 Insulin regulated PKC isoform mRNA in rat adipocytes. Diabetes Res Clin Prac 33:159-167.
4. Caceres JF, Kornblihtt AR 2002 Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 18:186-193.
5. Eperon IC, Makarova OV, Mayeda A, Munroe SH, Caceres JF, Hayward DG, Krainer AR 2000 Selection of alternative 5′ splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol Cell Biol 20:8303-8318.
6. Kosaki A, Webster NJ 1993 Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2hepatoma cells. J Biol Chem 268:21990-21996.
7. Hastings ML, Wilson CM, Munroe SH 2001 A purine-rich intronic element enhances alternative splicing of thyroid hormone receptor mRNA. RNA 7:859-874.
8. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ 2001 Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22:451-476.
9. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89.
10. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G 2003 Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202-3211.
11. Van den Berghe G 2002 Dynamic neuroendocrine responses to critical illness. Frontiers Neuroendocrinol 23:370-391.
12. Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF 1997 Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 82:4032-4036.
13. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR 2003 Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. Am J Physiol Endocrinol Metab 284:E228-E236.
14. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. New Engl J Med 345:1359-1367.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE 1985 APACHE II: a severity of disease classification system. Crit Care Med 13:818-829.
16. Keene AR, Cullen DJ 1983 Therapeutic Intervention Scoring System: update 1983. Crit Care Med 11:1-3.
17. Miranda DR, de Rijk A, Schaufeli W 1996 Simplified Therapeutic Intervention Scoring System: the TISS-28 items-results from a multicenter study. Crit Care Med 24:64-73.
18. Visser TJ, Docter R, Hennemann G 1977 Radioimmunoassay of reverse tri-iodothyronine. J Endocrinol 73:395-396.
19. Bakker O 2001 Dual color detection of splice variants of the c-erbA α (thyroid hormone receptor α) gene. In: Meuer F, Wittwer C, Nakagawara K (eds) Rapid Cycle Real-Time PCR: Methods and Applications. Springer-Verlag, Heidelberg, pp 91-96.
20. Timmer DC, Bakker O, Wiersinga WM 2003 Triiodothyronine affects the alternative splicing of thyroid hormone receptor alpha mRNA. J Endocrinol 179:217-225.
21. Wiersinga WM 2005 Nonthyroidal illness. In: Braverman LE, Utiger RD (eds) The Thyroid, 8th ed., Lippincott, Philadelphia, pp 246-263.
22. Peeters RP, van der Geyten S, Wouters PJ, Darras VM, van Toor H, Kaptein E, Visser TJ, Van den Berghe GJ 2005 Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab 90:6498-6507.
23. Weekers F, Michalaki M, Coopmans W, Van Herck E, Veldhuis JD, Darras VM, Van den Berghe G 2004 Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin releasing hormone and insulin infusion in a rabbit model of prolonged critical illness. Endocrinology 145:205-213.
24. Van den Berghe G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD, Bowers CY, Bouillon R 1999 Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone inpatients with protracted critical illness. J Clin Endocrinol Metab 84:1311-1323.
25. Magri F, Muzzoni B, Cravello L, Fioravanti M, Busconi L, Camozzi D, Vignati G, Ferrari E 2002 Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. Metabolism 51:105-109.
26. 3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90:4559-4565.
27. Williams GR, Franklyn JA, Neuberger JM, Sheppard MC 1989 Thyroid hormone receptor expression in the "sick euthyroid" syndrome. Lancet 334:1477-1481.
28. Amma LL, Campos-Barros A, Wang Z, Vennström B, Forrest D 2001 Distinct tissue-specific roles for thyroid hormone receptors β and α1 in regulation of type 1 deiodinase expression. Mol Endocrinol 15:467-475.
29. Boelen A, Wiersinga WM, Koehrle J 2006 Contributions of cytokines to non-thyroidal illness. Curr Opinion Endocrinol Diabetes 13:444-450.
30. Xiao SH, Manley JL 1998 Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2. EMBO J 17:6359-6367.
31. 3-receptor mRNAs in the fasted rat measured using competitive PCR. Biochem Biophys Res Commun 242:492-496.